tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GUTS Stock Latest News

B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
The FlyB. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
9d ago
ALT
PFE
Fractyl Health price target lowered to $22 from $26 at BofA
PremiumThe Fly
Fractyl Health price target lowered to $22 from $26 at BofA
25d ago
GUTS
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
PremiumPress Releases
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
26d ago
GUTS
PremiumCompany Announcements
Fractyl Health Updates Clinical Studies and Corporate Slides
27d ago
8K
GUTS
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
PremiumPress Releases
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
27d ago
GUTS
Fractyl Health to accelerate its REMAIN-1 clinical study
PremiumThe FlyFractyl Health to accelerate its REMAIN-1 clinical study
27d ago
GUTS
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
PremiumPress Releases
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
28d ago
GUTS
Fractyl Health’s Rejuva pancreatic gene therapy shows efficacy in presentation
PremiumThe Fly
Fractyl Health’s Rejuva pancreatic gene therapy shows efficacy in presentation
2M ago
GUTS
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
PremiumPress Releases
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
2M ago
GUTS
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
PremiumPress Releases
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
2M ago
GUTS
Fractyl Health’s Revita shows improvement in Type 2 diabetes in German study
PremiumThe Fly
Fractyl Health’s Revita shows improvement in Type 2 diabetes in German study
2M ago
GUTS
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
PremiumPress Releases
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
2M ago
GUTS
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
PremiumPress ReleasesFractyl Health to Present at BofA Securities 2024 Health Care Conference
2M ago
GUTS
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
PremiumPress Releases
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
3M ago
GUTS
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
PremiumPress Releases
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
3M ago
GUTS
Fractyl Health appoints Kimber as Chief Commercial Officer
PremiumThe Fly
Fractyl Health appoints Kimber as Chief Commercial Officer
4M ago
GUTS
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
PremiumPress Releases
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
4M ago
GUTS
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4M ago
GUTS
Fractyl Health reports Q4 EPS ($11.18) vs ($7.39) last year
PremiumThe Fly
Fractyl Health reports Q4 EPS ($11.18) vs ($7.39) last year
4M ago
GUTS
PremiumCompany AnnouncementsFractyl Health Gains FDA Nod to Investigate Revita Device
4M ago
8K
GUTS
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
PremiumPress Releases
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
4M ago
GUTS
Fractyl Health receives FDA IDE approval for Revita Remain-1 pivotal study
PremiumThe Fly
Fractyl Health receives FDA IDE approval for Revita Remain-1 pivotal study
4M ago
GUTS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >